Market Overview

UPDATE: J.P. Morgan Raises PT on ExlService Holdings on F4Q Results, Investor Day

Related EXLS
Health Alliance Plan Launches EXL Healthcare's CareRadius Suite
Here's Which IT Stocks Benefit From Healthcare M&A

In a report published Monday, J.P. Morgan reiterated its Neutral rating on ExlService Holdings (NASDAQ: EXLS), and raised its price target from $32.00 to $34.00.

J.P. Morgan noted, “Last Friday, EXLS reported in-line F4Q results and hosted its investor day in NYC. Overall takeaways were positive as EXLS's medium-term growth should accelerate, benefiting from expanding sales force and service/delivery capabilities. Moreover, management commentary on demand environment was more positive than last year (and peers), as the company is seeing healthy build up of large sized contracts in its pipeline. We believe EXLS clearly has the leadership position in the US insurance vertical for BPO services, and is going to increasingly invest in its healthcare/F&A/platforms/analytics businesses over the near term. The company's near-term margins should expand, but we expect steady margins beyond that (already above peers).”

ExlService Holdings closed on Friday at $31.81.

Latest Ratings for EXLS

Jul 2016CitigroupMaintainsBuy
May 2016CitigroupMaintainsBuy
Feb 2016JefferiesMaintainsHold

View More Analyst Ratings for EXLS
View the Latest Analyst Ratings

Posted-In: J.P. MorganAnalyst Color Price Target Analyst Ratings


Related Articles (EXLS)

View Comments and Join the Discussion!